CCGView

CCGView

RXA CCGView

With the RXA CCGView tool you can:

  • Analyse up to 5 years of NHS prescribing and other sales data
  • See data for all 20,000+ products prescribed by UK GPs, including branded and generic products
  • Select a range of reporting dimensions and filters
    • GP Practice
    • Product
    • Brand vs. Generic
    • Dispensing doctor
  • Access extensive highly visual, easy to interpret analytics
  • View extensive tables, charts and maps in the purpose built dashboard
  • Export all data and graphics for ad-hoc analytics and report building – (E.g. Excel, CSV, jpeg and PDF)
We make analytics simple
Request your demonstration today
"The RXA CCGView tool provides comprehensive analysis of the detailed prescribing for an NHS CCG or LHB, down to GP practice level."
Andrew Norman, Director

Key benefits? Adaptability, flexibility for future changes and cloud-based.

General Manager, Global Healthcare Company

At a CCG level we can show our customers how we can work with individual surgeries to get substantial cost savings and utilise their budgets better. We work with medicines management teams to help them to save money whilst also improving outcomes.

Country Manager UK, Leading Diagnostics Company

Our sales team use RX Analyser to analyse results and opportunity; it’s used by management to measure performance and identify national trends to drive targeting and strategy.

National Sales Manager, UK Pharmaceutical Company

I am regularly told by my sales team that Inspiremed’s software is one of the best tools in sales, measurement and planning that they’ve ever used.

National Sales Manager, Leading UK Pharmaceutical Company

I am extremely happy with the model and with the working relationship we have with Inspiremed.

Country Manager UK, Leading Diagnostics Company

If I had to choose one feature about Rx Analyser it would be the market overview, which gives a great snapshot of the market from practice up to National level.

Sales and Marketing Manager, Leading Healthcare Company, 2016

Sign up for added insights